YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017
This table browses all dspace content
Issue DateTitleJournal Title
2024Predictive value of plaque characteristics for identification of lesions causing ischemiaINTERNATIONAL JOURNAL OF CARDIOLOGY
2024Multi-center Korean cohort study based on RNA-sequencing data targeting COPD patients SCIENTIFIC DATA
2024Development and validation of an interpretable model for predicting sepsis mortality across care settings SCIENTIFIC REPORTS
2024Carbapenem-resistant Acinetobacter baumannii Outbreak in a COVID-19 Isolation Ward and Successful Outbreak Control with Infection Control Measures INFECTION AND CHEMOTHERAPY
2024Ten-year trends of antibiotics used for patients with pneumonia at long-term care hospitals in the Republic of Korea: An analysis based on national health insurance claims data HELIYON
2024The effect of dialysis modality on annual mortality: A prospective cohort study SCIENTIFIC REPORTS
2024Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: the ASPIRE (efficAcy and safety of aPixaban in rEal-world practice in Korean frail patients with atrial fibrillation) study FRONTIERS IN CARDIOVASCULAR MEDICINE
2024Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study JOURNAL OF CLINICAL ONCOLOGY
2024Soluble programmed death-1 is a useful indicator for mortality in patients with adult-onset Still's diseaseINTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
2024Trends, clinical characteristics, antimicrobial susceptibility patterns, and outcomes of Campylobacter bacteraemia: a multicentre retrospective studyINFECTION
2024Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphoma ONCOLOGIST
2024Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editingJOURNAL OF CONTROLLED RELEASE
2024염증성 장질환 치료 약물들의 악성 종양 발생 위험 Korean Journal of Gastroenterology
2024Feasibility of the Threshold-Based Quantification of Myocardial Fibrosis on Cardiac CT as a Prognostic Marker in Nonischemic Dilated Cardiomyopathy KOREAN JOURNAL OF RADIOLOGY
2024A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trialJOURNAL OF CLINICAL ONCOLOGY
2024Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2-metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL.JOURNAL OF CLINICAL ONCOLOGY
2024Safety and anti-tumor activity of BAY 2927088 in patients with <i>HER2</i>-mutant NSCLC: Results from an expansion cohort of the SOHO-01 phase I/II study.JOURNAL OF CLINICAL ONCOLOGY
2024Subcutaneous amivantamab and lazertinib as first-line treatment in patients with <i>EGFR</i>-mutated, advanced non-small cell lung cancer (NSCLC): Results from the phase 2 PALOMA-2 study.JOURNAL OF CLINICAL ONCOLOGY
2024Exploring Molecular Genetic Alterations and RAF Fusions in Melanoma: A Belvarafenib Expanded Access Program in Patients with RAS/RAF-Mutant Melanoma ONCOLOGIST
2024Effects of protein-enriched nutritional support on skeletal muscle mass and rehabilitative outcomes in brain tumor patients: a randomized controlled trial SCIENTIFIC REPORTS
1 40 4142434445464748495051 748
  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links